Difference between revisions of "TC99m Biomarker Committee"
Jump to navigation
Jump to search
| Line 19: | Line 19: | ||
*[[Media:2018_08-14_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | August 14, 2018]] | *[[Media:2018_08-14_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | August 14, 2018]] | ||
*[[Media:2018_07-10_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | July 10, 2018]] | *[[Media:2018_07-10_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | July 10, 2018]] | ||
| + | |||
| + | '''''[[SPECT TC99m BC Call Summaries Archive]]''''' | ||
==Profile Development== | ==Profile Development== | ||
Revision as of 14:19, 3 July 2019
- Co-chairs: Yuni Dewaraja, PhD; Robert Miyaoka, PhD
- RSNA Staff Support: Julie Lisiecki
Full name of biomarker committee: Technetium-99m for body, oncology, and immunology
Recent Meetings/Call Summaries
- May 14, 2019
- April 9, 2019
- March 12, 2019
- February 12, 2019
- January 15, 2019
- November 13, 2018
- October 9, 2018
- September 11, 2018
- August 14, 2018
- July 10, 2018
SPECT TC99m BC Call Summaries Archive